Background: Clostridioides difficile infection (CDI) is the leading cause of hospital-acquired
infectious diarrhoea. CDI is potentially preventable and can disrupt hospital services. The …

Background Clostridioides difficile infection (CDI) is associated with significant morbidity and
mortality in both healthcare and community settings. We aimed to define the predisposing …

Background Limited data currently exist on the incidence of Clostridioides difficile infection
(CDI) in Saudi Arabia. Compliance with CDI treatment guidelines is prudent for proper …

Background Clostridioides difficile infection (CDI) is a major cause of diarrhea in
hospitalized adult patients. This study aims to evaluate the clinical characteristics, clinical …

Discussion These guidelines reflect the evolving evidence base for CDI treatment.
Fidaxomicin and vancomycin are recommended over metronidazole, and fidaxomicin is the …

In recently updated international guidelines, fidaxomicin is preferentially recommended as
first-line treatment over vancomycin both for the first episode of CDI and for rCDI, based on …

Abstract The Clostridioides difficile Infection (CDI) treatment guidelines were published in
2021; however, the incorporation of these recommendations into clinical practice was rather …

Prevention and treatment of recurrent Clostridioides diffici... : Current Opinion in Infectious
Diseases Prevention and treatment of recurrent Clostridioides difficile infection : Current Opinion …

Clostridioides difficile is a dangerous human pathogen because it can grow to high numbers
in the intestine, cause colitis with its potent toxins, and persist as spores. C. difficile infection …

Background Clostridioides difficile infection (CDI), characterized primarily by diffuse diarrhea
in the setting of recent healthcare and antibiotic exposure, maintains significantly high rates …